Viewing a single comment thread. View all comments

ReadsAndLearns t1_j7mq5gf wrote

Have you'll experimented with single cell Multiomic platforms like 10x or Missionbio?

The major benefit that I see with single cell data is that it provides clonal information which aren't available in bulk methods. Do you see any benefits of these technologies in drug discovery? Can they help improve your models?

1

IHaque_Recursion t1_j7n2ly1 wrote

I can’t comment about all of our internal technologies. But! We did recently publish work with our collaborators at Genentech on benchmarking methods to builds maps of biology, which we evaluated on both our phenomics data and (publicly-available) 10x scRNA-seq (Perturb-seq) data – check it out here. So, draw your own conclusions…

2